According to the findings of a clinical experiment done by scientists at the National Institutes of Health (NIH), individuals with low-grade lymphomatoid granulomatosis who receive immunotherapy known as interferon alfa-2b can live for decades after being diagnosed. Epstein-Barr virus infection…